Related AMPAkines
Other AMPAkine drugs from Cortex Pharmaceuticals such as CX-546 and CX-614 have already been researched for use in treating Alzheimer's disease and ADHD. These drugs were reasonably effective at reducing the symptoms of Alzheimer's and it was hoped that they could also slow the progression of the disease, but both CX-546 and CX-614 have poor bioavailability, and are only active at very high doses of 1000 mg or more. CX-717 and CX-1739 are newer and more potent drugs in the same series. The chemical structures of CX-717 and CX-1739 have not yet been revealed by Cortex Pharmaceuticals, but are presumably similar to earlier compounds in the series as shown below. It is very unusual for research on a compound to be released in scientific journals without disclosing exactly what the compound consists of, but this information is likely to have been kept confidential for reasons of intellectual property, and also because the research on CX-717 was initially partially funded by DARPA, the United States Defense Advanced Research Projects Agency.
Read more about this topic: CX717
Famous quotes containing the word related:
“Perhaps it is nothingness which is real and our dream which is non-existent, but then we feel think that these musical phrases, and the notions related to the dream, are nothing too. We will die, but our hostages are the divine captives who will follow our chance. And death with them is somewhat less bitter, less inglorious, perhaps less probable.”
—Marcel Proust (1871–1922)